In patients treated with semaglutide, weight loss continued over 65 weeks and was sustained for up to 4 years
Early trials suggest it may enhance trust, emotional connection, and therapeutic alliance, making it a compelling tool for relational repair during treatment (Lee et al., 2016)
Because both pathways tend to decline with age, especially in your 40s and 50s, they may work well together for people focused on supporting long-term function and healthy aging
This article examines the current evidence on tirzepatide and antibiotic use, practical management strategies, and what patients should discuss with their healthcare providers
Guideline 3: Intramuscular vs
Huberman went on to acknowledge the potential of BPC-157 but stresses the need for more robust human clinical trials to validate its use in injury recovery and broader applications for longevity